- Home
- AKAN vs ISPC Comparison
AKAN vs ISPC Comparison
Compare AKAN & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAN
- ISPC
- Stock Information
- Founded
- AKAN 2021
- ISPC 2009
- Country
- AKAN Canada
- ISPC United States
- Employees
- AKAN N/A
- ISPC N/A
- Industry
- AKAN Medicinal Chemicals and Botanical Products
- ISPC Precision Instruments
- Sector
- AKAN Health Care
- ISPC Health Care
- Exchange
- AKAN Nasdaq
- ISPC Nasdaq
- Market Cap
- AKAN 3.2M
- ISPC 3.1M
- IPO Year
- AKAN 2022
- ISPC 2021
- Fundamental
- Price
- AKAN $1.37
- ISPC $0.99
- Analyst Decision
- AKAN
- ISPC
- Analyst Count
- AKAN 0
- ISPC 0
- Target Price
- AKAN N/A
- ISPC N/A
- AVG Volume (30 Days)
- AKAN 63.6K
- ISPC 44.7K
- Earning Date
- AKAN 07-15-2025
- ISPC 08-05-2025
- Dividend Yield
- AKAN N/A
- ISPC N/A
- EPS Growth
- AKAN N/A
- ISPC N/A
- EPS
- AKAN N/A
- ISPC N/A
- Revenue
- AKAN $836,664.00
- ISPC $8,058,631.00
- Revenue This Year
- AKAN N/A
- ISPC $35.93
- Revenue Next Year
- AKAN N/A
- ISPC N/A
- P/E Ratio
- AKAN N/A
- ISPC N/A
- Revenue Growth
- AKAN 97.47
- ISPC N/A
- 52 Week Low
- AKAN $0.93
- ISPC $0.86
- 52 Week High
- AKAN $5.08
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- AKAN 53.56
- ISPC 43.82
- Support Level
- AKAN $1.28
- ISPC $0.90
- Resistance Level
- AKAN $1.49
- ISPC $1.03
- Average True Range (ATR)
- AKAN 0.09
- ISPC 0.07
- MACD
- AKAN -0.00
- ISPC -0.00
- Stochastic Oscillator
- AKAN 57.89
- ISPC 36.03
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.